Medical and Pharmaceutical Health Canada approves Zepbound for obstructive sleep apnea in adults with obesity The disorder can cause excessive daytime sleepiness and increase the risk of serious health problems Joseph MortonJune 24, 2026
News Shionogi to buy out Apnimed stake in sleep apnea venture for up to USD$150 million Shionogi will take full ownership and control of the venture’s pipeline Joseph MortonMarch 27, 2026
Sleep Medical cannabis proves its worth for combatting sleep apnea: 5-year study Nearly 40% of all study participants reported significant improvements Rowan DunneMay 15, 2025
Sleep Global CPAP devices market to be worth US$5.25B by 2030: Straits Research North America will dominate the market due to strong healthcare facilities and leading insurance providers Rowan DunneOctober 17, 2022